APA (7th ed.) Citation

Ward, M. A., Fang, G., Richards, K. L., Walko, C. M., Earnshaw, S. R., Happe, L. E., & Blalock, S. J. Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Ward, Melea A., Gang Fang, Kristy L. Richards, Christine M. Walko, Stephanie R. Earnshaw, Laura E. Happe, and Susan J. Blalock. Treatment Interruption and Regimen Change in Firstgeneration Versus Second-generation Tyrosine Kinase Inhibitors Used as First-line Therapy for Chronic Myeloid Leukemia. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Ward, Melea A., et al. Treatment Interruption and Regimen Change in Firstgeneration Versus Second-generation Tyrosine Kinase Inhibitors Used as First-line Therapy for Chronic Myeloid Leukemia. Columbia Data Analytics, LLC.